TY - JOUR
KW - Adult
KW - California/epidemiology
KW - Cost-Benefit Analysis
KW - Female
KW - Humans
KW - Male
KW - Methadone/therapeutic use
KW - Narcotics/therapeutic use
KW - Opiate Substitution Treatment/economics
KW - Opioid-Related Disorders/drug therapy/epidemiology
KW - Quality-Adjusted Life Years
AU - E. Krebs
AU - B. Enns
AU - E. Evans
AU - D. Urada
AU - M. D. Anglin
AU - R. A. Rawson
AU - Y. I. Hser
AU - B. Nosyk
A1 - 
BT - Annals of Internal Medicine
C5 - Opioids & Substance Use; Financing & Sustainability; Healthcare Policy
CP - 1
CY - United States
DO - 10.7326/M17-0611
IS - 1
JF - Annals of Internal Medicine
PP - United States
PY - 2018
SN - 1539-3704; 0003-4819
SP - 10
EP - 19
EP - 
T1 - Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California
T2 - Annals of Internal Medicine
TI - Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California
U1 - Opioids & Substance Use; Financing & Sustainability; Healthcare Policy
U2 - 29159398
U3 - 10.7326/M17-0611
VL - 168
VO - 1539-3704; 0003-4819
Y1 - 2018
ER -